Responses by Breast and Prostate Cancer Patients to Out-Of-Pocket Costs in Newfoundland and Labrador

Abstract

Purpose: Cancer patients face substantial care-related out-of-pocket (oop) costs that may influence treatment decisions, attitudes, and use of drug- or appointment-related cost-saving strategies. We examined the relationship between oop costs and care-related responses by patients. Methods: We surveyed 170 prostate and 131 breast cancer patients presenting at clinics or support groups, or listed on the cancer registry in Newfoundland and Labrador. Results: In the 3-month period before the survey, 18.8% of prostate and 25.2% of breast cancer patients had oop costs greater than $500. Those oop costs consumed more than 7.5% of quarterly household income for 15.9% of prostate and 19.1% of breast cancer patients. Few patients (8.8% prostate, 15.3% breast) ever adopted any drug- or appointment-related cost-saving strategy. Few patients (7.2% prostate, 9.6% breast) said oop costs influenced treatment decisions, told their physicians about their oop costs (27.0% prostate, 21.1% breast), or were aware of available financial assistance programs (27.3% prostate, 36.9% breast). Compared with patients having low or moderate oop costs (22.9% prostate, 16.7% breast, and 25.7% prostate, 58.3% breast respectively), a larger proportion of prostate (56.0%) and breast (58.3%) cancer patients with high oop costs said that those costs created stress. Among prostate cancer patients, a larger proportion of those having high oop costs (compared with low or moderate costs) used drug-related (22.2% vs. 3.3% and 9.6% respectively) and appointment-related (11.1% vs. 1.1% and 3.8% respectively) cost-saving strategies, said oop costs created an unusual amount of stress (48.0% vs. 18.4% and 10.4%), and had difficulty paying those costs (29.2% vs. 6.2% and 10.4%). Conclusions: For a small group of breast and prostate cancer patients, oop costs are high, but rarely lead to the use of care-related cost-saving strategies or influence care decisions.

Alone in a Crowd? Parents of Children with Rare Diseases’ Experiences of Navigating the Healthcare System

“…Out-of-pocket payments and changes to employment were common among participants in this study. While research in cancer care has also identified out-of-pocket payments as an unanticipated consequence of illness for Canadian patients (Housser et al 2013;Longo and Bereza 2011), unlike cancer treatments which are often time-limited, the participants in our study anticipated these costs for the duration of their children's lives. There was also a gendered aspect of this finding, as the majority of participants were women (N = 15) and many reported either decreasing their employment to part-time or leaving the workforce entirely in order to care for their children during times when they were hospitalized or to attend numerous appointments.…”

"It's at a Time in Your Life When You Are Most Vulnerable": A Qualitative Exploration of the Financial Impact of a Cancer Diagnosis and Implications for Financial Protection in Health

“…The extent of financial adjustments needed varies in all settings but more extreme measures such a refinancing homes [ 37 ] or house repossessions [ 23 ] have been reported in both the US and the UK. Forgoing treatment or rationing medications because of cost has been described in other settings [ 6 , 38 – 42 ] although Housser et al [ 43 ] recently reported that care-related cost savings were generally rare among breast and prostate patients in Canada. In our setting, patients were sometimes referred to OSWs to avoid this but none of the patients interviewed reported making treatment decisions based on cost/affordability.…”

Using Healthcare Services: Perspectives of Community‐Dwelling Aging Adults With Intellectual Disabilities and Family Members

“…Third, our findings illustrated the potential financial burden of using healthcare services. Previous research on out‐of‐pocket costs for Canadians has mainly focused on cancer patients (e.g., de Oliveira et al, ; Housser et al, ). Unlike cancer patients, who will experience these costs for the duration of their disease treatment, individuals with ID will be obligated to these costs for their adult years and the costs will likely rise with increasing age and frailty.…”